<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?</h2>
    <div class="badge">2025-09-15T13:40:02+00:00</div>
    <ul>
      <li>The stock is up 56.2% year-to-date.</li>
<li>The industry has moved +3.6% so far this year.</li>
<li>Based on the most recent data, BSX has returned 15% so far this year.</li>
<li>Meanwhile, the Medical sector has returned an average of -1.8% on a year-to-date basis.</li>
<li>Over the past three months, Akero Therapeutics, Inc.&#x27;s consensus EPS estimate for the current year has increased 2.7%.</li>
<li>Over the past 90 days, the Zacks Consensus Estimate for BSX&#x27;s full-year earnings has moved 2.1% higher.</li>
<li>On average, stocks in this group have gained 6.7% this year, meaning that BSX is performing better in terms of year-to-date returns.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?\n• The stock is up 56.2% year-to-date.\n• The industry has moved +3.6% so far this year.\n• Based on the most recent data, BSX has returned 15% so far this year.\n• Meanwhile, the Medical sector has returned an average of -1.8% on a year-to-date basis.\n• Over the past three months, Akero Therapeutics, Inc.&#x27;s consensus EPS estimate for the current year has increased 2.7%.\n• Over the past 90 days, the Zacks Consensus Estimate for BSX&#x27;s full-year earnings has moved 2.1% higher.\n• On average, stocks in this group have gained 6.7% this year, meaning that BSX is performing better in terms of year-to-date returns." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/boston-scientific-bsx-outperforming-other-134002772.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>